Key facts
- Notable investors include Enterprise Ireland.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Allworth Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Allworth Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Allworth Diagnostics
Developer of home-based monitoring devices intended for individuals managing inherited metabolic conditions. The company's platform utilises proprietary engineered enzymes, advanced optical sensing, a handheld reader and smartphone-connected cloud analytics to measure key blood biomarkers from a finger-prick, enabling patients, caregivers, and healthcare providers to monitor trends over time and support more timely clinical management.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2023
- Employees
- 2
- Website
- allworthdiagnostics.com/
- Ownership
- Privately Held (backing)
Allworth Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Allworth Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Allworth Diagnostics in its N-PORT filings yet. We sweep new filings monthly.